CY 5031

· Cytokinetics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CY 5031, covering 2024-08-13 to 2024-08-13. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 3, Open-Label Extension of COURAGE-ALS (CY 5031) [Phase 3]